Left Atrial Appendage Occlusion Guided by 3D Printing
NCT03330210 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2020-03-10
Summary
Left atrial appendage closure (LAAC) was approved by the ESC guidelines as a stroke prevention alternative to warfarin for patients with nonvalvular atrial fibrillation in patients at high risk of bleeding (IIbB).
Although the overall LAAC benefice, in term of prevention of stroke or embolisme and decresing the anticoagulant-related risk of bleeding is already demonstrated, however the procedure success and safety, critically depends on understanding LAA anatomy and adequate pre-procedure planning.
3D-printed patient-specific adaptive and flexible LA models have demonstrated in a previous study an improving in LAAO device sizing, a better pre-procedural planning of the optimal trans-septal puncture site, by incorporating all anatomical variations and an improuving patient outcomes by reducing procedure time and number of prostheses employed per patient.
This technique is now used in several surgical centers in France and large prospective evaluation of the practice is necessary.
Conditions
Interventions
- PROCEDURE
-
3D printing
Manufacturing and use of a model printed in 3D
Sponsors & Collaborators
-
Hôpital Privé Les Franciscaines
collaborator OTHER -
Henri Mondor University Hospital
collaborator OTHER -
Rangueil Hospital
collaborator OTHER -
Clinique Pasteur Toulouse
collaborator OTHER -
University Hospital, Bordeaux
collaborator OTHER -
Clinique du Millenaire
collaborator OTHER -
Clinique Saint Pierre - Perpignan
collaborator UNKNOWN -
Hôpital Dupuytren
collaborator OTHER -
Hospital St. Joseph, Marseille, France
collaborator OTHER -
European Georges Pompidou Hospital
collaborator OTHER -
University Hospital, Grenoble
collaborator OTHER -
University Hospital, Lille
collaborator OTHER -
University Hospital, Montpellier
lead OTHER
Principal Investigators
-
Vlad CIOBOTARU · Hôpital Privé Les Franciscaines
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-01
- Primary Completion
- 2019-12-01
- Completion
- 2019-12-01
Countries
- France
Study Locations
More Related Trials
-
LDD in Treatment of Femoropopliteal ISR
NCT03521843 ·Status: UNKNOWN ·Phase: NA
-
Study of DA+LDD in the Treatment of Femoropopliteal Occlusive Disease
NCT03380650 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Peri-surgical Results at Short and Mean Terms of the GORE ® Excluder Iliac Branch Endoprosthesis
NCT03312127 ·Status: TERMINATED ·Phase: NA
-
Tack Optimized Drug Coated Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries
NCT02802306 ·Status: COMPLETED ·Phase: NA
-
Evaluation of All'InCath in Peripheral Vasculature Percutaneous Transluminal Angioplasty.
NCT05153421 ·Status: TERMINATED ·Phase: NA
-
Carotid Stenting in Patients With High Risk Carotid Stenosis ("Soft Plaque")
NCT01274676 ·Status: COMPLETED ·Phase: NA
-
DRug-Eluting BallOOn Versus Primary Polymer-coated Paclitaxel Eluting STenting for Femoro-popliteal Lesions
NCT06835660 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
PacLitaxel Eluting Balloon Application In Sfa In Stent Restenosis
NCT01587482 ·Status: COMPLETED
-
Local Paclitaxel Delivery to Prevent Restenosis in Peripheral Arterial Disease
NCT03858764 ·Status: WITHDRAWN
-
Atherectomy and Drug-Coated Balloon Angioplasty in Treatment of Long Infrapopliteal Lesions
NCT01763476 ·Status: COMPLETED ·Phase: NA
-
Comparison of Angioplasty/Drug Coated Balloon/Laser + Drug Coated Balloon for Femoropopliteal Artery In-stent Restenosis
NCT02599389 ·Status: UNKNOWN ·Phase: PHASE3
-
Registry of Patients Treated by Preloaded Fenestrated Stent-graft Designs for Complex Endovascular Aortic Procedures
NCT05141123 ·Status: COMPLETED
-
PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator DevicE
NCT03001700 ·Status: COMPLETED ·Phase: NA
-
Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis
NCT01083030 ·Status: COMPLETED ·Phase: PHASE3
-
IN.PACT™ AV Access IDE Study
NCT03041467 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Rotational Atherectomy System Associated With Drug Coated Balloon Angioplasty in Limb Ischemia
NCT04276311 ·Status: UNKNOWN ·Phase: NA
-
REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions
NCT02580955 ·Status: UNKNOWN ·Phase: PHASE3
-
Expression of GLP1 Receptor on Peripheral Blood Mononuclear Cells in Advanced Peripheral Artery Disease: Paving the Way for GLP1R Agonists Treatment in Chronic Limb Threatening Ischemia
NCT07340112 ·Status: NOT_YET_RECRUITING
-
Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation
NCT05450042 ·Status: RECRUITING ·Phase: NA
-
Iliac Vein Stenting in Advanced Chronic Venous Insufficiency
NCT02149212 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of All'InCath in Peripheral Vasculature Percutaneous Transluminal Angioplasty.
NCT05497440 ·Status: WITHDRAWN ·Phase: NA
-
Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries
NCT02522884 ·Status: COMPLETED ·Phase: NA
-
Study of IN.PACT Amphirion™ Drug Eluting Balloon vs. Standard PTA for the Treatment of Below the Knee Critical Limb Ischemia
NCT00941733 ·Status: COMPLETED ·Phase: NA
-
IN.PACT Admiral Drug-Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Superficial Femoral Artery (SFA) and Proximal Popliteal Artery (PPA)
NCT01566461 ·Status: COMPLETED ·Phase: NA
-
The Study of Active Transfer of Plaque Technique for Unprotected Distal Left Main Bifurcation Lesions
NCT02127138 ·Status: UNKNOWN ·Phase: NA